B超联合个性化选择药物治疗无排卵型功能失调性子宫出血疗效分析

摘要

目的:分析B超联合个性化选择药物治疗无排卵型功能失调性子宫出血的临床效果.方法:将231例无排卵型功能失调性子宫出血患者随机分为对照组(n=40)及试验组(n=191).试验组根据患者子宫内膜厚度、出血量、Hb值分为试验A组(n=78)、试验B组(n=68)、试验C组(n=45).对照组采用妈富隆进行治疗;试验A、B、C组分别采用妈富隆、炔诺酮、醋酸甲羟孕酮进行治疗.结果:对照组、试验A、B、C组治疗总有效率分别为92.50％、100.00％、95.59％、93.33％,试验A、B组明显高于对照组(P＜0.01).试验组各组治疗总有效率均高于对照组(P＜0.05);且试验A组高于试验B、C组,试验B组高于试验C组(P＜0.05).结论:个性化选择药物能有效提高无排卵型功能失调性子宫出血的治疗效果.%Objective:To analyze the clinical effect of B ultrasound combined with individualized drug selection in anovulatory dysfunctional uterine bleeding.Methods:A total of 231 patients with anovulatory dysfunctional uterine bleeding were randomly divided into control group(n =40) and experimental group(n =191).The exprimental group was further divided into group A,B,C acorrding to the endometrial thickness,bleeding volume and Hb value.The control group was given Marvelon,and exprimental group A,B,C were respectively given Marvelon,Norethisterone and Medroxyprogesterone.Results:The effective rates in experimental group A,B,C were 100.0％,95.59％,93.33％,which were higher than that in the control group (92.50) (P ＜ 0.05).Conclusion:Individualized drug selection can significantly improve the treatment effect of anovulatory dysfunctional uterine bleeding.